Four recent articles based on multi-gene panel testing, published in high impact oncology journals, have concluded that there are no associations between pathogenic variants in three syndromic genes (NF1, PTEN and STK11) and breast cancer risk.1–4 Whilst these analyses have identified potential new gene associations, the negative results concerning syndromic associations should be tempered. This evidence concerns the gene PTEN and breast carcinoma.